Live Breaking News & Updates on Ilan Vaknin

Stay updated with breaking news from Ilan vaknin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences

TEL AVIV, Israel, May 17, 2024 Chemomab Therapeutics Ltd. , a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today. ....

United States , Hebrew University , Barbara Lindheim , Ilan Vaknin , Amnon Peled , International Convention , Gordon Research Conference On Chemotactic Cytokines , Strategic Communications , Chemomab Therapeutics Ltd , Gordon Research Conference , Chemomab Corporate Development , Hadassah University Hospital , Chemotactic Cytokines , Annual Congress , European Association , Research Conference , Cytokines Conference , Vice President , Translational Science , Stellate Cell Biology Poster Tour , San Diego June , One On Partnering , Public Relations ,

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare. ....

Barbara Lindheim , Wadi Mor , Raanan Greenman , Rifaat Safadi , Avi Katav , John Lawler , Homer Levi , Douglas Thorburn , Chris Cirillo , Irina Koffler , Matthew Frankel , Shelia Sherlock , Tom Snir , Christopher Bowlus , Ilan Vaknin , Massimo Pinzani , Hepatology At University College London , Prnewswire Chemomab Therapeutics Ltd , Digestive Health , Institute For Liver , Data Monitoring Committee , Strategic Communications , Lifesci Advisors , Chemomab Therapeutics Ltd , New Proteomics Data Further Confirms , Sclerosing Cholangitis ,

Patient Data Presented at 2023 EULAR Congress Highlights How Serum CCL24 Levels Can Predict Vascular and Fibrotic Complications of Systemic Sclerosis

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of. ....

United Kingdom , Rebecca Ross , Hilit Levi , Ilan Vaknin , Irina Koffler , Wadi Mor , Barbara Lindheim , Prnewswire Chemomab Therapeutics Ltd , Strategic Communications , European Congress , Lifesci Advisors , Leeds Institute Of Rheumatic , Chemomab Therapeutics Ltd , University Of Leeds , European Alliance Of Association , New Patient Data Further Implicates , Fibrotic Disease Pathology , Neutralizing Antibody , Systemic Sclerosis , European Alliance , Italy May , Professor Enrico De Lorenzis , Leeds Institute , Musculoskeletal Diseases , Professor De Lorenzis , Chief Scientific Officer ,

Chemomab Therapeutics to Present at Upcoming Scientific Conferences

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of. ....

United States , Crowne Plaza Woburn , Irina Koffler , Ilan Vaknin , Barbara Lindheim , Wadi Mor , Fibrotic Drug Development , Lifesci Advisors , Chemomab Therapeutics Ltd , Progressive Biomarkers In Clinical Development , Waltere Washington Convention Center , Strategic Communications , Prnewswire Chemomab Therapeutics Ltd , Union Late , Union World Conference On Lung Health , Convention Center , Attenuates Biliary Inflammation , Neutrophil Recruitment , Vice President , World Conference , Lung Health , Lung Damage Derived , Union Late Breaker , Chief Scientific Officer , Annual Anti Fibrotic Drug Development , Leveraging Fibrosis Inflammatory Biomarkers ,

Chemomab Adds Highly Experienced Executives Further Strengthening Its R&D and Clinical Capabilities

/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of. ....

Israel General , Dale Pfost , Irina Koffler , Ilan Vaknin , Barbara Lindheim , Bristol Myers Squibb , Lifesci Advisors , Compugen Ltd , Chemomab Therapeutics Ltd , University Of Tennessee , Research Development , Rhodes College , Strategic Communications , Prnewswire Chemomab Therapeutics Ltd , Hebrew University Of Jerusalem , Health Sciences , Clinical Development , Appoints Ilan Vaknin , Vice President , Christina Crater , Chief Executive Officer , Preclinical Bioassays , Chief Technology Officer , External Scientific Consultant , Weizmann Institute , Hebrew University ,